1 Acta Haematologica This journal includes coverage of current hematology research. All manuscripts are subject to editorial review. Manuscripts intended for rapid communication must present new findings of sufficient importance to justify their accelerated acceptance. Proofs are checked by the Main Editor and not sent to the authors. Review will be rapid, and once accepted, the paper will be included in the next planned issue. Karger s N/A Switzerland http://content.karger.c om/produktedb/produ kte.asp?aktion=journ alhome&produktnr=2 23829&ContentOnly=f alse 2 American Journal of This journal provides broad coverage of both human and animal hematologic topics. The journal publishes original contributions from investigators and clinicians in hematology and related areas such as immunology, blood banking, and cell biology. The journal includes original laboratory and clinical studies, concise reviews, brief reports, images in hematology, clinical studies in hemostasis and thrombosis, letters and correspondence, and occasional in-depth reviews of selected topics. John Wiley & Sons N/A United States http://www3.interscien ce.wiley.com/cgibin/jhome/35105 3 Annals of This journal covers clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including the diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors as well as transplantation of hematopoietic stem cells. formation is also presented on general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. All articles are peerreviewed Springer N/A Germany http://springer.lib.tsing hua.edu.cn/(vjm4vs55 1wylohqzvc53safz)/ap p/home/journal.asp?re ferrer=parent&backto= linkingpublicationresult s,1:100397,1 1
4 Anticancer Research This journal is an independent international forum devoted to the rapid publication of original high quality articles and reviews on all aspects of experimental and clinical oncology. Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months from acceptance are guaranteed. The journal was established in 1981 and is published bimonthly. Each annual volume contains six issues and index. Each issue may be divided into two parts (A: Experimental studies, and B: Clinical and epidemiological studies). Special issues, presenting the proceedings of meetings or groups of papers on topics of significant progress, will also be included in each volume. J. G. Delinassios- Athens ternational stitute of Anticancer Research; ternational Conferences of Anticancer Research Greece http://www.iiaranticancer.org/rese arch/research_index.htm 5 Bone Marrow Transplantation This journal is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation. The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 24 issues a year. Nature Publishing Group N/A United Kingdom http://www.nature.co m/bmt/index.html 6 Cancer Research The journal publishes original studies, reviews, and perspectives on all areas of basic, clinical, translational, epidemiological, and prevention research in cancer and the cancer-related biomedical sciences. All submitted manuscripts are assessed by a Senior Editor, who makes the final recommendation on acceptance or rejection. The Senior Editor will take one of the following steps: 1) send the manuscript to an Associate Editor, who selects peer reviewers and makes a recommendation based on their comments; 2) directly select peer reviewers for the manuscript; or 3) determine that the manuscript is not suitable for the journal and return it, without peer review. American Association for Cancer Research N/A United States http://cancerres.aacrjo urnals.org/ 2
7 Clinical Breast Cancer This journal is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches. Cancer formation Group (CIG) N/A United States http://www.cancerinf ormationgroup.com/ breast.html 8 Clinical Lymphoma and Myeloma This journal is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma and myeloma. All manuscripts are subjected to peer review, typically 2 in number. Usually one of the reviewers is a member of the Editorial Board and the other is an outside expert chosen for his/her knowledge and scope of the subject matter of the manuscript. Cancer formation Group N/A United States http://www.cancerinfor mationgroup.com/lym phoma.html 9 European Haematology This journal publishes manuscripts on molecular, cellular and clinical research on diseases of the blood, vascular and lymphatic tissue, and on basic molecular and cellular research related to normal development and function of the blood, vascular and lymphatic tissue. Also included are reviews on clinical haematology and basic research, case reports, and clinical pictures. Received manuscripts are sent to an associate editor with particular expertise in the field and two independent reviewers approved by the associate editor. The reviewers' reports are sent to the associate editor who recommends on the fate of the manuscript to the Editor-in-Chief. Blackwell Publishing N/A Denmark http://www.blackwellpu blishing.com/journal.a sp?ref=0902-4441&site=1 3
10 Haematologica/ The Journal Articles published in this journal are reviewed by at least two different external referees (second step or classical peer-review). After this peer evaluation, the final decision on a paper's acceptability for publication is made by an Associate Editor in conjunction with one of the editors. This journal requires authors, reviewers and editors to declare any potential conflict of interest. addition, the journal itself will disclose any financial relationship with advertising clients and sponsors. Ferrata Storti Foundation European Association Italy http://www.haematolog ica.org/index.html 11 This journal publishes original and review articles concerning oncology, pathology, biology, clinical research and epidemiology. Taylor & Francis N/A United Kingdom http://journalsonline.ta ndf.co.uk/(cqu0xd45px tcbtmnq4z0v155)/app/ home/journal.asp?refe rrer=parent&backto=li nkingpublicationresult s,1:104284,1&linkin 4
12 ternational This journal presents research papers on all aspects of clinical oncology that report the results of novel and timely Clinical Oncology investigations. Also included are reports on clinical trials and experimental studies that are relevant to clinical oncology. Papers are subject to peer review by at least two referees and the Editors. Springer N/A Japan http://www.springer.co m/west/home/biomed? SGWID=4-124-70-1139824-0 13 ternational The journal provides reviewed publications in the fields of clinical and experimental hematology. Papers, case reports, rapid communications, and review articles are accepted for consideration by the Editorial Board. Carden Jennings Publishing Co The Japanese Society of Japan http://www.ijhonline.com/ 14 ternational Oncology 15 Leukemia and Lymphoma All material submitted will be subject to review by appropriate referees selected by the Editorial Office. This journal publishes full-length papers and reviews on clinical and therapeutic practice, epidemiological studies and outcomes analysis, laboratory diagnosis, pathology, cytology, ultrastructure, cytogenetics and cellular and molecular immunology of hematologic malignancies. Letters and correspondence to the editors are also accepted on all topics, Spandidos Publications University of Crete, Faculty of Medicine Greece http://147.52.72.117/ij O/ijo.htm Taylor & Francis N/A United Kingdom http://www.tandf.co.uk/ journals/journal.asp?is sn=1042-8194&linktype=1 16 Leukemia Research This journal publishes basic and (or) applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies; and articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology and molecular biology as well as epidemiologic and clinical studies. All manuscripts are peer-reviewed. Pergamon Press N/A United Kingdom http://intl.elsevierhealt h.com/journals/lere/de fault.cfm 5
17 Lung Cancer The journal publishes full-length articles of original research on clinical and basic science aspects of topics represented by the fields of interest of Lung Cancer (prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities). Short communications, technical notes and reviews may also be published. All full-length articles will be peer-reviewed and the decision of the Editorin-Chief, as advised by the reviewers, is final. Elsevier N/A Ireland http://ees.elsevier.com /lungcancer/ 18 The Oncologist This journal is devoted to medical and practice issues for surgical, radiation, and medical oncologists and is designed specifically for the busy practitioner entrusted with the care of adult or pediatric cancer patients. With emphasis on clear, concise interpretation, this international peer-reviewed journal publishes original papers, reviews, and commentaries addressing the multimodality diagnosis, treatment, and quality of life of the cancer patient. Manuscripts are reviewed by two or more experts in the field and, when accepted, are published with haste generally within 12 weeks. When a contribution is of such relevance as to significantly impact public health, authors may request Fast Track Review for a Rapid Communication, in which case an editorial decision will be made within 2 weeks of submission. AlphaMed Press N/A United States http://theoncologist. alphamedpress.org/ 19 Seminars in 20 Seminars in Oncology This journal focuses on subjects of current importance in clinical hematology and related fields. Each issue examines a single topic of clinical importance including each cancer's biology, epidemiology, and pathophysiology, its clinical presentation, therapeutic options, and follow-up measures. W.B. Saunders N/A United States http://journals.elsevier health.com/periodicals /yshem/home W.B. Saunders N/A United States http://www.us.elsevier health.com/product.js p?isbn=00937754#aut horinfo 21 Seminars in Thrombosis and Hemostasis This review journal focuses on all issues relating to hemostatic and thrombotic disorders, including hemophilia A & B, thrombophilia, gene therapy, venous and arterial thrombosis, von Willebrand disease, vascular disorders and thromboembolic diseases. Thieme N/A United States http://www.thiemeconnect.de/ejournals/t oc/sth 6